Success Stories

Link to PCOS and fertility success stories

Prof. Nadir: Publications

Journals
Reviews and Editorial
Book Chapters
Books Edited

Journals

  1. NR Farid. Otitis media in children. Sud Med J 6: 152, 1968
  2. NR Farid and SA Ismail. Dermatomyositis and recurrent carcinoma of the thyroid. Sud. Med J 7: 63, 1969.
  3. AS Omer and NR Farid. Post infarction ventricular septal defect: a case report and review of the literature. Sud Med J 8: 112, 1970.
  4. NR Farid and J Anderson. SLE-like reaction after phenylbutazone. Lancet. 1, 1022, 1971.
  5. NR Farid, RJ Johnson and TW Lowe. Haemolytic reaction due to mefanimic acid. Lancet 2, 382, 1971.
  6. NR Farid and D Evered. Renal tubular acidosis. B Med J 4: 233, 1971.
  7. NR Farid and J Anderson. A low pressure system for filtration for micronephelometry. Clin Chemica Act 39, 236, 1972.
  8. NR Farid and J Anderson. Cerebrovascular disease and hyperlipoproteinemia. Lancet 1: 1398, 1972.
  9. NR Farid, JP Glynn and DNS Kerr. Haemodialysis in paracetamol self- poisoning. Lancet 2: 336, 1972.
  10. Farid, R Menzies and J Anderson. Micronephelometry in the estimation of serum triglycerides. Lancet 2: 1090, 1972.
  11. Cerebrovascular disease and hyperlipoproteinemia. Am Heart J. (Annotation) 85: 430, 1973.
  12. NR Farid, RE Munro, VV Row and R Volpe. Thyroxine in thyroiditis. Lancet 1: 151, 1973.
  13. NR Farid, RE Munro and VV Row. Cell-mediated immunity in thyroid disease. Br Med J 1: 677, 1973.
  14. NR Farid, RE Munro, VV Row and R Volpe. Peripheral thymus-dependent (T) lymphocytes in Graves' disease and Hashimoto's thyroiditis. N Engl J Med 288: 1313, 1973.
  15. NR Farid, E Wilkinson, FL Constable and J Anderson. Basement membrane thickness of rectal capillaries in diabetes. Lancet 1: 837, 1973.
  16. NR Farid and J Anderson. Immunoglobulins and complement in diabetes mellitus. Lancet 2: 92, 1973.
  17. NR Farid, C von Westarp, VV Row and R Volpe. Increase in T lymphocytes in Graves' disease. Lancet 2: 204, 1973.
  18. NR Farid, RE Munro, VV Row and R Volpe. Rosette inhibition test for the demonstration of thymus dependent lymphocyte sensitization in Graves' disease and Hashimoto's thyroiditis. N Engl J Med 289: 1111, 1973.
  19. NR Farid, VV Row and R Volpe. T cell rosettes in thyrotoxic Graves' disease. N Engl J Med 289: 1145, 1973.
  20. NR Farid, A Martin and J Anderson. Insulin and fibrinolytic activity. Lancet 2: 1270, 1973.
  21. NR Farid, RE Munro, VV Row and R Volpe. The use of E rosette as a test of remission in Graves' disease treated with antithyroid drugs. Clin Endocrinol 3: 55, 1974.
  22. NR Farid, J Anderson, A Martin and D Weightman. Fibrinolytic activity and treatment of diabetes. Lancet 1: 631, 1974.
  23. NR Farid, RE Munro, VV Row and R Volpe. E. rosette inhibition test of T lmphocyte sensitization. B Med J 1: 635, 1974.
  24. R Volpe, NR Farid, C von Westarp and VV Row. The pathogenesis of Graves'disease and Hashimoto's thyroiditis: a viewpoint. Clin Endocrinol 3: 239, 1974.
  25. NR Farid, VV Row and R Volpe. E rosette formation specific for T lymphocytes. N Engl J Med 291: 109, 1974.
  26. NR Farid, C von Westarp, VV Row and R Volpe. Rosette inhibition test. N Engl J Med 290: 109, 1974.
  27. NR Farid. Fibrinolytic activity and treatment of diabetes. Lancet 2: 220, 1974.
  28. NR Farid, P Dickinson, IR MacNeal and J Anderson. Hyperlipoproteinemia in peripheral arterial disease in the north of England. J Cardiovas Surg 15: 366, 1974.
  29. NR Farid, C von Westarp, VV Row and R Volpe. Studies of cell-mediated immunity (CMI) in relatives of patients with Graves' disease. J Clin Endocrin & Metabolism, 39: 779, 1974.
  30. R Volpe, NR Farid, C von Westarp and VV Row. LATS and Graves' disease. Lancet 2: 842, 1974.
  31. W Pruzanskhi, NR Farid, E Keystone, M Armstrong and MF Greaves. The influence of homogeneous cold agglutinins on B and T lymphocytes. Clin Immunol Immunopathol 4: 248, 1975.
  32. W Pruzanski, NR Farid, E Keystone and M Armstrong. The influence of homogeneous cold agglutinins on polymorphonuclear and mononuclear monocytes. Clin Immunol Immunopathol 4: 277, 1975.
  33. NR Farid, J Barnard, C Kutas, EP Noel and W Marshall. HLA antigens in Graves' disease and Hashimoto's thyroiditis. Inter Archiv Allerg 49: 837, 1975.
  34. NR Farid, EP Noel, J M Barnard and WH Marshall. Lymphocytotoxic antibodies in Graves' disease and Hashimoto's thyroiditis. IRCS Med Sci 3: 532, 1975.
  35. EP Noel and NR Farid. Lymphocytotoxic antibodies in organ-specific autoimmune disease. Lancet 2: 502, 1975.
  36. NR Farid, BL Griffiths, J Collins, WH Marshall and DW Ingram Blood coagulation and fibrinolysis in thyroid disease. Thrombosis and Haemostasis 34: 415, 1976.
  37. NR Farid, EP Noel and E Kutas. A population of human lymphocytes staining for esterases. Experientia 32: 340, 1976.
  38. NR Farid, EP Noel, JM Barnard and WH Marshall. Differential effect of cold agglutinins on lymphocytes from patients with Graves' disease and Hashimoto's thyroiditis. Cell Immunol 22: 394, 1976.
  39. NR Farid, JM Barnard and WH Marshall. The association of HLA with autoimmune thyroid disease in Newfoundland; the influence of HLA homozygosity in Graves' disease. Tissue Antigens 8: 181, 1976.
  40. S Hood, JD Vaughan-Jackson and NR Farid. Inappropriate TSH secretion. Paradoxical rise in serum TSH in response to thyroxine therapy. J Clin Endocrinol Metab 43: 1360, 1976.
  41. NR Farid, B Au, G Woodford and R K Chandra. Polymorphonuclear leucocyte function in hypothyroidism. Horm Res 7: 247, 1976.
  42. EP Noel, JM Barnard and NR Farid. One way mixed lymphocyte culture in autoimmune thyroid disease. IRCS Med Sci. 5: 1980, 1977.
  43. NR Farid and C Kennedy. The assessment of a method for the measurement of serum thyroxine by radioimmunoassay using polyethylene glycol precipitation. Clin Chem 23: 1333, 1977.
  44. EP Noel, L Osmond, L Sampson and NR Farid. Mitogen-induced transformation of lymphocytes from patients with autoimmune thyroid disease - 1 Dose response relationship. IRCS Med Sci 5: 358, 1977.
  45. EP Noel, L Osmond, L Sampson and NR Farid. Mitogen-induced transformation of lymphocytes from patients with autoimmune thyroid disease - 2. Kinetics of the response. IRCS Med Sci 5: 359, 1977.
  46. NR Farid, JM Barnard, WH Marshall, I Woolfrey and RF O'Driscol. Thyroid autoimmune disease in a large Newfoundland family: the influence of HLA. J Clin Endocrinol Metab 45: 1165, 1977.
  47. NR Farid, JM Barnard and D Bryant. HLA and PTC testing in autoimmune thyroid disease. Tissue Antigens 10: 414, 1977.
  48. NR Farid, RM Newton, EP Noel and WH Marshall. Gm phenotypes in autoimmune thyroid disease. J Immunogenet 4: 429, 1977.
  49. K Kutty, D Bryant and NR Farid. Serum lipids in hypothyroidism - a reassessment. J Clin Endocrinol Metab 46: 55, 1978.
  50. NR Farid, RM Newton, EP Noel and JM Barnard. The operation of immunological networks in autoimmune thyroid disease. Tissue Antigens 12: 205, 1978.
  51. NR Farid, JM Barnard, L Sampson, EP Noel and WH Marshall. The HLA-Bw4/w6 diallelic system in Graves' disease. Tissue Antigens 11: 294, 1978.
  52. B Larsen, B Pepper and NR Farid. HLA-Bf haplotypes in a Newfoundland family. Tissue Antigens 12: 39, 1978.
  53. NE Carter, CM West, JM Barnard, NR Farid, B Larsen and WH Marshall. Linkage of glyoxalase I and HLA in two Newfoundland communities. Hum Heredit 28: 397, 1978.
  54. H Moens and NR Farid. Hashimoto's thyroiditis is associated with HLA DRw3. N Engl J Med 299: 133, 1978.
  55. NR Farid, JM Barnard, B Pepper, EP Noel, F Kelly, AJ Davis, C Hobeika and WH Marshall. The association of HLA with juvenile diabetes in Newfoundland. Tissue Antigens 12: 215, 1978.
  56. NR Farid, L Sampson, EP Noel, JM Barnard, R Mandeville, B Larsen and WH Marshall. A study of HLA D related antigens in Graves' disease. J Clin Invest 61: 108, 1979.
  57. H Jenkins and NR Farid. Subacute thyroiditis-like syndromes-relation to HLA. Tissue Antigens 13: 167, 1979.
  58. NR Farid, L Sampson, P Noel, JM Barnard and AJ Davis. HLA D related (DRw) antigens in juvenile diabetes mellitus. Diabetes 28: 552, 1979.
  59. H Moens, JM Barnard, J Bear and NR Farid. The association of HLA-B8 with atrophic thyroiditis. Tissue Antigens 13: 5. 1979.
  60. B Pepper and NR Farid. Polymorphic variants of the third component of complement in Graves' disease. Human Heredit 29: 279, 1979.
  61. H Moens, RH Payne, ND Carter and NR Farid. Association of glyoxalase I allotypes with Graves' disease and juvenile diabetes mellitus. Human Heredit 30: 62, 1980.
  62. NR Farid, H Moens, B Larsen, R Payne, K Saltman, F Fifield and D Ingram. HLA haplotypes in familial Graves' disease. Tissue Antigens 15: 492, 1980.
  63. EP Noel and L Sampson, BM Pepper and NR Farid. Polymorphism of the second component of complement (C2) in Graves' disease. Human Heredit 30: 245, 1980.
  64. NR Farid, B Larsen, R Payne, EP Noel and L Sampson. Polyglandular autoimmune disease and HLA. Tissue Antigen 16: 23, 1980.
  65. J Dornan, P Allan, EP Noel, B Larsen and NR Farid. Properdin factor B (Bf) allele BfF1 specifies and HLA-B18 diabetogenic haplotype. Diabetes 29: 423, 1980.
  66. NR Farid, EP Noel, L Sampson and N Russell. Prolactin secreting pituitary adenomata are possible associated with HLA-B8. Tissue Antigens 15: 33, 1980.
  67. J Dornan, J Barnard and NR Farid. Lack of close linkage of hypogonadotropic hypogonadism with HLA. Tissue Antigens 15: 410, 1980.
  68. NR Farid. Polyglandular failure syndrome. Ann Intern Med 92: 442, 1980.
  69. NR Farid. HLA DRw antigens and juvenile diabetes - evidence for genetic rogeneity. Proceedings of Symposium for Nordic Council for Artic Medical Research 26: 67, 1980.
  70. NR Farid, E Stone and G Johnson. Graves' disease and HLA: Clinical and epidemiologic associations. Clin Endocrinol 13: 535, 1980.
  71. NR Farid, S Buehler, N Russell, F Maroun and HS Smyth. Prolactinomas in familial multiple endocrine neoplasia syndrome type I (MEN-1) relationship to HLA and carcinoid tumors. Am J Med 69: 874, 1980.
  72. B Pepper, EP Noel and NR Farid. The putative anti-thyrotropin receptor antibodies of Graves' disease I Gm allotypes. J Immunogenet 8: 89, 1981.
  73. W Tom and NR Farid. Reduced C4 in HLA-B8 positive patients with Graves' disease. Human Heredit 31: 227, 1981.
  74. J Dornan, P Allan, EP Noel, L Sampson and NR Farid. Alleles of the second component of complement (C2) in insulin dependent diabetes mellitus. Human Heredit 31: 211, 1981.
  75. NR Farid, L Sampson, H Moens and JM Barnard. The association of goitrous autoimmune thyroiditis with HLA-DR5. Tissue Antigens 17: 265, 1981.
  76. V Stenszky, Cs Balazs, L Kozma, A Leovey and NR Farid. HLA control of thyroglobulin-induced blast-transformation in Graves' disease. Human Heredit 31: 322, 1981.
  77. DN Churchill and NR Farid. Proteinuria in Hashimoto's thyroiditis (C). N Engl J Med 305: 1286, 1981.
  78. TF Davis, M Platzer and NR Farid. Prediction of therapeutic response to radioactive iodine in Graves' disease using TSH-receptor antibodies and HLA-status. Clin Endocrinol 16:183, 1982.
  79. NR Farid, R Briones-Urbina and MN Islam. Biological activity of anti-thyrotropin anti-idiotypic antibody. J Cell Biochem 119: 305, 1982.
  80. R Briones-Urbina, JC Bear and NR Farid. Association of hypergammaglobulinemia G with HLA-DR3 in Graves' disease. Tissue Antigens 19: 20, 1982.
  81. NR Farid and JC Bear. Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease. Nature 295: 629, 1982.
  82. A Tong, NR Farid and V Stenszky. Two sisters, one with Graves' disease and the second with thyroiditis and transient hyperthyroidism. Acta Medica Hungarica 39: 7, 1982.
  83. S Hoddinott, J Dornan, JC Bear and NR Farid. Immunoglobulin levels, immunodeficiency and HLA in Type I (insulin-dependent) diabetes mellitus. Diabetologia 23: 326, 1982.
  84. BS Hawe, PG Walfish and NR Farid. HLA antigens in painless thyroiditis with transient hyperthyroidism. Tissue Antigens 19: 211, 1982.
  85. Y Nako, H Matsumoto, T Miyazaki and NR Farid. IgG heavy chain allotypes (Gm) in atrophic goitrous thyroiditis. J Immunogenet 9: 311, 1982.
  86. PG Walfish and NR Farid. Post-partum thyroid dysfunction (C). N Engl J Med 307: 1024, 1982.
  87. MN Islam, B Pepper, R Briones-Urbina and NR Farid. Biological activity of anti-thyrotropin anti-idiotypic antibody. Europ J Immunol 13: 57, 1983.
  88. MN Islam, R Briones-Urbina, G Bako and NR Farid. Surface labeling of thyrocytes isolated by a new method combining enzymatic digestion and percoll gradient centrifugation. Anal Biochem 130: 260, 1983.
  89. V Stenszky, Cs Balazs, L Kozma, Sz Rochlitz, JD Bear and NR Farid. Identification of subsets of patients with Graves' disease by cluster analysis. Clin Endocrinol 18:335, 1983.
  90. PG Walfish, IS Gotesman, AB Shewchuk, J Bain, BS Hawe and NR Farid. Association of premature ovarian failure with HLA antigens. Tissue Antigens 21: 168, 1983.
  91. MN Islam, R Briones, G Bako and NR Farid. Both TSH and thyroid stimulating antibody of Graves' disease bind to an Mr 197,000 holoreceptor. Endocrinology 113: 436, 1983.
  92. V Stenszky, L Kozma, Cs Balazs and NR Farid. HLA-DR associations with Graves' disease in Eastern Hungary. Clin Invest Med 6: 181, 1983.
  93. NR Farid, BS Hawe and PG Walfish. Increased frequency of HLA-DR3 and 5 in the syndromes of painless thyroiditis with transient thyrotoxicosis: Evidence for an autoimmune aetiology. Clin Endocrinol 19: 699, 1983.
  94. Cs Balazs, V Stenszky, L Kozma and NR Farid. Specific suppressor T cell function in a patient with Graves' disease and her identical healthy twin. Clin Endocrinol 20: 683, 1984.
  95. Cs Balazs and NR Farid. Effect of triiodothyronine in the short-lived and concanavalin-A generated suppresser T-cell functions. Clin Investig Med 7: 157, 1984.
  96. J Dornan, JG O'Leary and NR Farid. Dopamine control of prolactin secretion in multiple endocrine neoplasia. Clin Investig Med 7: 161, 1984.
  97. WH Marshall, JM Barnard, D Churchill, NR Farid, R Grandy, B Larsen, RJ Payne, WM Skanes, GC Ebers, DW Paty, H Mervart and M Schroeder. Study of alleles of the second complement component (C2) on Canadian HLA haplotypes. Tissue Antigens 23: 299:239, 1984.
  98. JC Bear, R Briones-Urbina, J Fahey and NR Farid. Variant multiple endocrine neoplasia I (MEN I Burin): further studies and non-linkage to HLA. Human Heredity 31: 15, 1985.
  99. MN Islam and NR Farid. Structure of the porcine thyrotropin receptor: A 200 kilodalton glycoprotein heterocomplex. Experientia 41, 18, 1985.
  100. NR Farid. Anti-hormone anti-idiotypes are probes for receptor structure and function. Immunology Letters 9: 191, 1985.
  101. G Bako, NM Islam and NR Farid. Photoaffinity labelling of the porcine thyrotropin receptor - effective of Graves' immunogloblin G and anti-TSH anti-idiotypic antibodies. Clin Investig Med 8: 126, 1985.
  102. V Skanes, B Larsen, L Sampson-Murphy and NR Farid. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus. Clin Investig Med 8: 152, 1985.
  103. L Kozma, V Stenszky, E Kraszits, Cs Balazs, NR Farid. The association of IgG heavy-chain allotypes (Gm) with Graves' disease in Hungary. Clin Expl Immunogenet 2: 154-157, 1985.
  104. V Stenszky, L Kozma, Cs Balazs, SZ Rochlitz, JC Bear and NR Farid. The genetics of Graves' disease: HLA and disease susceptibility. J Clin Endo Metab 61: 735, 1985.
  105. NR Farid and C Thompson. HLA and autoimmune endocrine disease 1985. Mol Biol & Med 3: 85-97, 1986.
  106. M Preus, MF Frecker, V Stenszky, Cs Balazs and NR Farid. A prognostic score for Graves' disease. Clinical Endo 23: 653-661, 1985.
  107. VM Skanes, J Barnard, NR Farid, WH Marshall, L Murphy, D Rideout, R Taylor, G Xidos and B Larsen. Class III alleles and high risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis. Mol Biol & Med 3: 143-157, 1986.
  108. V Stenszky, L Kozma, Cs Balazs, JC Bear and NR Farid. The role of HLA antigens in the manifestation and course of Graves' disease. Mol Biol & Med 3: 53-62, 1986.
  109. MF Frecker, M Preus, L Kozma, E Kraszits, V Stenszky, Cs Balazs and NR Farid. Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers. Mol Biol & Med 3: 63-71, 1986.
  110. C Thompson and NR Farid. Post-partum thyroiditis and goitrous (Hashimoto's) thyroiditis are associated with HLA-DR4. Immunology Letters 11: 301-303, 1985.
  111. Cs Balazs, F Juhasz, V Stenszky, L Kozma and NR Farid. The relation of susceptibility to and biologic behaviour of thyroid epithelial cell cancer to HLA. Cancer 58: 52-54, 1986.
  112. NM Islam, R Tuppal, BS Hawe, R Briones-Urbina and NR Farid. The thyroid "microsomal" antigen is an epitope on the thyroid receptor. J Cell Biochem 31: 107-120, 1986.
  113. F Juhasz, Gy Balazs, L Kozma, E Kraszits, V Stenszky and NR Farid. Interaction of IgG heavy chain allotypes (Gm) and HLA in conferring susceptibility to thyroid carcinoma. Clinical Endocrinol 25: 17-22, 1986.
  114. Cs Balazs, E Kiss, A Leovey and NR Farid. The immunosuppressive effects of methimozole on cell-mediated immunity is mediated by its capacity to inhibit peroxidase and to scavenge free oxygen radicals. Clinical Endocrinol 25: 7-16, 1986.
  115. B Althaus, JJ Staub, TM Neri, M Hauenstein, J Mullerbrand, W Berger and NR Farid. HLA-DR3 and DRw6-prognostic factors for the incidence of hypothyroidism in Graves' disease after radioiodine treatment. Acta Endocrinologica 113: 323-328, 1986.
  116. Cs Balazs, M Levai, V Stenszky and NR Farid. Identification of lymphocyte subsets in peripheral blood and thyroid gland in Graves' disease by alpha-naphthyyl-acetate-esterase reaction. Acta Medica Hungarica 43: 381-387, 1986.
  117. R Briones Urbina, MN Islam, J Ivanyi and NR Farid. Use of anti-idiotypic antibodies as probes for the interactions of TSH sub units with its receptor. J Cell Biochem 34: 151,1987.
  118. V Stenszky, L Kozma, Gy Szegedi and NR Farid. Interplay of immunoglobulin G heavy chain markers (Gm) and HLA in predisposing to systemic lupus nephritis. J Immunogenetics 13: 11-17, 1986.
  119. V Stenszky, L Kozma, Gy Szegedi, I Sonkoly, JC Bear and NR Farid. Heterogeneity of systemic lupus erythematosus elucidated by cluster analysis: the influence of HLA. J Immunogenetics 13: 327-340, 1986.
  120. B Larsen, C Thompson, A Kwan and NR Farid. Lack of association of HLA with thyroid cancer: an effect of iodine sufficiency and safe environment? Tissue Antigens 28: 298-300, 1986.
  121. V Stenszky, E Kraszits, F Juhazs, L Kozma, Cs Balazs and NR Farid. Association of goitrous autoimmune thyroiditis with HLA-DR3 in Eastern Hungary. J Immunogenetics 14: 143-148, 1987.
  122. M Frecker, V Stenszky, Cs Balaz, L Kozma, E Kraszits and NR Farid. Genetic factors in Graves' ophthalmopathy. Clinical Endocrinology 25: 479, 1987.
  123. E Bodolay, Gy Szegedi, V Stenszky, Cs Balazs and NR Farid. Expression of HLA-DR antigens by thyroid cells: The effect of Graves' IgG. Immunology Letters 15: 77, 1987.
  124. B Hawe, TF Davies and NR Farid. An anti-idiotypic antibody against Graves' IgG. Immunol Letters 15; 96, 1987.
  125. A Demaine, K Welsh, B Hawe and NR Farid. Polymorphism of the immunoglobulin heavy chain T cell receptor beta chain genes in Graves' disease. Acta Endocrinol 115, suppl. 281: 149, 1987.
  126. NR Farid and GE Fahraeus Van-Ree. About the porcine TSH receptor. Acta Endocrinol 112, suppl. 281: 152, 1987.
  127. BS Hawe and NR Farid. An anti-idiotypic antibody against Graves' IgG. Immunol Letters 15: 96, 1987.
  128. NR Farid, E Bodolay, Cs Balazs and V Stenszky. Induction of circulating activated suppresser-like T. cells by methimazole therapy for Graves' disease. N Engl J Med 248 (C), 1987.
  129. CS Mellor, NR Farid and DF Craig. Female hypersexuality treated with cyproterone acetate. Am J Psych 145: 1037, 1988 (letter).
  130. A Demaine, K Welsh, BS Hawe and NR Farid. Polymorphism and the T cell receptor beta chain in Graves' disease. J Clin Endocrinol Metab 65: 643, 1987.
  131. R Maheux, JG Parent, Y Samson, C Jean and NR Farid. Utilization of luteinizing hormone-releasing hormone agonist in pulmonary leiomyomatosis. Fertility and Sterility 48: 315-317, 1987.
  132. E Bodalay, P Suranyi, F Juhasz, V Stenszky, Cs Balazs and NR Farid. Methimazole blocks Graves' IgG but not interferon alpha HLA-DR expression by thyroid cells. Immunology Letters 18: 167-172, 1988.
  133. M Frecker, G Mercer, VM Skanes and NR Farid. Major histocompatibility complex (MHC) factors predisposing to and protecting against Graves' eye disease. Autoimmunity, 1, 307, 1988.
  134. JD Harnett, J Green, BC Cramer, G Johnson, P McManamon, NR Farid, W Pryse-Philips and PS Parfrey. The spectrum of renal disease in Bardet-Biedel Syndrome. N Engl J Med 319: 615, 1988.
  135. MH Gault, S Vasdev, L Longerich, E Johnson, NR Farid, Y Legal, V Prabhakaran and A Fine. Evidence for an adrenal contribution to plasma digitalis like factors. Clin Physiol Biochem 6: 253, 1988.
  136. Cs Balazs, E Kiss, and NR Farid. Time dependent effect of cyclosporin-A on TSH-receptor antibody synthesis in patients with Graves' disease. Acta Media Hungaria 45: 43-52, 1988.
  137. G Bako, MN Islam, M Vertes, NR Farid and A Leovey. Dot immunobinding assay for antibodies to TSH receptor. Radiobiol Radiother (Berl) 28: 595-600, 1987.
  138. P Dzwonkowski, J O'Leary and NR Farid. Thyroid papillary carcinoma in HLA identical sibs. Lancet (Letter) ii: 971, 1988.
  139. DN Posnett, A Gottlieb, J Bussel, S Friedman, N Chirorazzi, Y Li, NR Farid and MA Robinson. T cell antigen receptors in autoimmunity. J Immunol 141: 1963, 1988.
  140. Thomson, WP Robinson, MK Kuhner, S Joe, MJ MacDonald, J Gottschall, J Barbosa, SS Rich, J Bertrams, MP Baur, JL Partanen, BLD Tait, E Schober WM Mayr, J Ludvingsson, B Lindblom and NR Farid. Genetic heterogeneity, modes of inheritance and risk estimates for a joint study of caucasians with insulin dependent diabetes mellitus. Am J Hum Genet 43: 799-816, 1988.
  141. PS Parfrey, SM Griffiths, BJ Barrett, MD Paul, M Genge, J Withers, NR Farid and PJ McManamon. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. N Engl J Med 320: 143, 1989.
  142. Cs Balazs, A Bokk, I Molnar, V Stenszky and NR Farid. Graves' ophthalmopathy, eye muscle antibodies and HLA antigens. Expl Clin Immunogenet 6: 190, 1989.
  143. E Bodolay, F Bojan, Gy Szegedi, V Stenszky and NR Farid. Cytotoxic endothelial cell antibodies in mixed connective tissue disease. Immunology Letters 20: 163-168, 1989.
  144. P Boros, F Juhasz, G Szegedi, E Kraszits, V Stenszky and NR Farid. Immunogenetic and immunologic studies of differentiated thyroid carcinoma. Cancer 63: 1318, 1989.
  145. S Green, PS Parfrey, JD Harnett, BC Cramer, NR Farid, O Heath, PJ McManamon, E O'leary and W Pryse-Phillips. The cardinal manifestations of Bardet-Biedl syndrome, formerly Lawrence-Moon-Biedl syndrome. N Engl J Med 321: 1002-1008, 1989.
  146. Balazs, KissE, Farid,NR Effect of lithium on chemiluminescence of polymorphonuclear granulocytes and mononuclear cells of peripheral blood Acta Med Hung 46:31-42,1989
  147. P Suranyi, G Szegedi, S Damjanovich, F Juhasz, V Stenszky and NR Farid. B Lymphocyte subsets in Hashimoto's thyroiditis. Immunol Lett 22: 147-150, 1989.
  148. H Payami, S Joe, NR Farid, V Stenszky, SH Chan, PPB Yeo, JS Cheah and G Thomson. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves' disease. Am J Hum Genet 45: 541-546, 1989.
  149. E Olah, E Balogh, F Bojan, F Juhasz, V Stenszky and NR Farid. Cytogenetic analyses of three papillary carcinomas and a follicular adenoma of the thyroid. Cancer Genet Cytogenet 44: 119-129, 1990.
  150. GE Fahraeus Van-Ree and NR Farid. Immunocytochemical localization of bovine thyrotropin and thyroid auto-antibodies in porcine thyrocytes. Immunol Letter 23: 237, 1990.
  151. A Poloy, L Tibor, V Stenszky, G Fust and NR Farid. HLA-DR1 is association with vitiligo. Immunol Lett 27: 59-62, 1991.
  152. I Molnar, K Nemeti, A Bokk, Cs Balazs and NR Farid. Cellular and humoral autoimmune responses against human eye muscle membrane antigen in Graves' Disease. Acta Medica Hungarica 47: 43, 1990.
  153. YF Shi, H Schmidt, F Juhasz, V Stenszky, D Robb, and NR Farid. High rates of ras codon 61 mutation in thyroid tumors in an iodide deficient area. Cancer Research 51: 2690-2693, 1991.
  154. C Balazs and NR Farid. Soluble interleukin-2 receptor in sera of patients with Graves' disease. Journal of Autoimmunity, 4: 681-688, 1991.
  155. C Balazs, A Bokk, E Bodolay and NR Farid. Effect of ecogramostin on HLA class II antigen expression on thyrocytes. Lancet, 338: 1344, 1991.(letter).
  156. KK Ahring, JPK Ahring, C Joyce and NR Farid. Telephone modem access improves diabetes control in insulin-requiring diabetes. Diabetes Care, 15: 971-975, 1992.
  157. YF Shi, MJ Zou, D Robb and NR Farid. Typing for major histocompatibility complex class II in thyroid tissue blocks: association of Hashimoto's thyroiditis with HLA-DQA0301 and DQB0201 alleles. J Clin Endo and Metab, 75: 943-946, 1992.
  158. YF Shi, MJ Zou, RS Parhar and NR Farid. High affinity binding of thyrotropin to the extracellular domain of its receptor in transfected Chinese hamster ovary (CHO) cells. Thyroid 3: 129-133, 1993.
  159. MJ Zou, YF Shi, S Al-Sedairy and NR Farid. High levels of nm23 gene expression in the advanced stage of thyroid cancer. British J of Cancer 68: 385-388, 1993.
  160. YF Shi, MJ Zou, P Ahring and NR Farid. Exhibition of TSH-induced desensitization in TSH receptor transfected CHO cells: truncation of TSH receptor cytoplasmic tail does not affect homologous desensitization. Endocrine J, 1:157-162, 1993.
  161. YF Shi, MJ Zou and NR Farid. p53 mutations in all stages of thyroid carcinomas. J Clin Endo and Metab, 77: 1054-1058, 1993.
  162. YF Shi, MJ Zou, M Ahmed and NR Farid. The human TSH receptor gene - studies in physiology and pathology. Horm Metab Res, 25:632-636, 1993.
  163. YF Shi, MJ Zou and NR Farid. Expression of thyrotropin receptor gene in thyroid carcinoma is associated with good prognosis. Clinical Endocrinology, 39: 269-274, 1993.
  164. EJ Lewis, LG Hunsicker, RP Bain and RD Rohde for the Collaborative Study Group. The effect of Angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med, 329:1456-1462, 1993 (See Corrections: NEJM 330:152, 1994).
  165. MJ Zou, YF Shi and NR Farid. Low rate of ret proto-oncogene activation (PTC/retPTC) in papillary thyroid carcinomas from Saudi Arabia. Cancer, 73:176-180, 1994.
  166. YF Shi, MJ Zou, P Ahring and NR Farid. Frequent inactivation of the retinoblastoma gene in human thyroid carcinoma. Endocrine J 2,193-198, 1994.
  167. s Balázs, A Bokk and NR Farid. Serum soluble CD8 concentration is an indicator of disease activity in patients with Graves' disease. Thyroid, 4: 27-30, 1994.
  168. EM Petty, JS Reen, SJ Marx, RT Taggart, NR Farid and AE Bale. Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN Burin) to chromosome 11q evidence for a founder effect in patients from Newfoundland. AM J Hum Genet 54:1060-1066, 1994.
  169. MF Ahmad, V Stenszky, F Juhazs, Gy Balazs and NR Farid. No mutations in the translated region of exon 1 in the TSH-receptor in Graves' thyroid glands. Thyroid, 4: 151-153, 1994.
  170. YF Shi, R Parhar, MJ Zou, S Al-Sedairy and NR Farid. Differential nm23 expression at fetal/maternal interface. Brit J Cancer 70: 440-444, 1994.
  171. RS Parhar, Y Shi, M Zou, NR Farid, P Ernst and S Al-Sedairy. Effects of cytokine mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells. International Journal of Cancer, 60: 204-210, 1995.
  172. MJ Zou, YF Shi, S Al-Sedairy, SS Hussain, and NR Farid. Expression of mdm-2 gene, a p53 binding protein in thyroid carcinogenesis . Cancer, 76 :314-318,1995.
  173. YF Shi, MJ Zou, P Ahring and NR Farid. The thyrotropin receptor internalization is directed by a highly conserved motif in the seventh transmembrane region Endocrine, 3:409-414, 1995.
  174. YF Shi, MJ Zou, and NR Farid. Usage and regulation of the Gs( gene in thyroid cells.Endocrine 4, 277-282, 1996.
  175. NR Farid. Long term survivors of Human Immunodeficiency Virus Type I infection. N Engl J Med.332 :1647 (Letter).
  176. F Juhasz and NR Farid. Immune response to papillary thyroid carcinoma J. Clinical Endocrinology & Metabolism 81, 4175-4176, 1996.
  177. Y Shi, M Zou, NR Farid, ST Al-Sediary. Evidence of gene deletion of p21(WAF1/CIP1), a cyclin-dependent protien kinase inhibitor, in thyroid carcinomas. British J. Cancer 74,1336-1341, 1996.
  178. Cs Balazs, E Kiss, A Vamos, I Molnar and NR Farid. Beneficial effect of pentoxifylline on thyroid associated ophthalmopathy (TAO) J Clin Endocrin Metab. 82, 1999-2002,1997.
  179. CBalazs, E Kiss, A Vamos, I Molanr, NR Farid Immunomodulatory effect of pentoxifylline in Graves’ opthalmopathy Orv. Hetil 138:2869-2874,1997
  180. Balazs, E Kiss , NR Farid Inhibitory effect of pentoxiffylline on HLA-DR expression and glycosaminoglycan synthesis of retrobulbar fibroblasts induced by interferon gamma Acta Microbiol Immunol.Hung.44:173-179
  181. V Kaczur, Gy Vereb, I Molnar, G Krajczar, E Kiss, NR Farid and C Balazs. Effect of anti- thyroid peroxidase antibodies on thyroid peroxidase activity measured by chemiluminescence technique Clin. Chemistry 43:1392-1396,1997.
  182. MJ Zou, YF Shi, S Al-Sediary and NR Farid. Inverse correlation between cyclin D1 overexpression and retinoblastoma gene mutations in thyroid carcinoma. Endocrine 8:61-64,1998.
  183. C Balazs, E Kiss, and NR Farid. Inhibitory effects of Pentoxifylline of HLA-DR expression and glycosaminoglycan synthesis by retrobular fibroblasts. Horm. & Metab. Res.30:496-499,1999.
  184. Y Shi, RJ Parhar, MJ Zou, MM Hammami, Z-P Lum, NR Farid, S T Al-Sedairy, MC Paterson. Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) mRNA is elevated in advanced stages of thyroid cancer Brit Cancer J 79:1234-1239,1999.
  185. MJ Zou, Y Shi, NR Farid, ST Al-Sedairy, MC Paterson. FHIT gene abnormalities in both benign and malignant thyroid tumors Brit Cancer J 35:467-472,1999
  186. NR Farid, V Kaczur, C Balazs The human thyrotropin receptor is highly mutable: a review of gain-of-function mutations Europ. J Endocrinol 143:25-30, 2000.
  187. M-L Kottler, S Chauvin, N Lahlou, CE Harris, CJ Johnston, J-P Lagarde, P Bouchard, NR Farid, R Counis A new compound heterozygote mutation of the gonadotropin-releasing hormone receptor (L314X, Q106R) in a woman with complete hypogonadotropic hypogonadism: Chronic estrogen administration amplifies the gonadotropin defect J Clin Endocrin. Metab 85:3002-3008,2000.
  188. Y Shi, M Zou, NR Farid, MC Paterson Association of Fhit, a candidate tumor suppressor gene, with the ubiquitin-conjugating enzyme hUBC9 Biochemical Journal 352:443-448,2000 .
  189. B Shahedian, Y Shi, M Zou , NR Farid Thyroid carcinoma is characterized by genomic instability : Evidence from p53 mutations Mol Genetics and Metabolism. 72, 155-163, 2001
  190. C Kong, S Ellard, CJ Johnston, NRFarid Multiple Endocrine Neoplasia Type IBURIN from Mauritius : a novel MEN I mutation J Endocrin Investig 24:806-810.
  191. A Nagy, L Kozma, I Kiss, I Ember, I Takcas, J Hadju , NR Farid Copy number of cancer genes predict tumor grade and survival of pancreatic cancer Anticancer Res.21:1321-1325,2001.
  192. M Marga, A Denisova, A Sochnev, V Pirags, NR Farid Two HLA DRB1 alleles confer independent genetic susceptibility to Graves’ disease: The relevance of cross-population studies Am. J Med Genet. 102:188-191,2001
  193. Y Shi, M Zou, E Varkondi, A Nagy, L Kozma, NR Farid Cyclin D1 overexpression in thyroid carcinoma Thyroid 11:709-710,2001.
  194. NM Islam, CL Hew, V Kaczsur,NR Farid Cleavage of the thyrotropin receptor J.Endocrinol.Invest. 24 :833-835 , 2001.
  195. C Balazs, NR Farid Soluble CD4 concentration is an indicator of relapse of postpartum thyroiditis J. Endo. Invest 25:11-17,2002
  196. LE Kimball, Kulinskaya, B Brown, C Johnston, NR Farid Does smoking increase relapse rates in Graves’ disease ? J Endo. Invest. 25:152-157,2002
  197. C Balazs , NR Farid MHC Class II expression in Graves’ hyperthyroidism Thyroid 12:181-182,2002.
  198. NR Farid Immunodeficiency and Type I Diabetes New Eng J Med 346:538-539,2002.
  199. Z Mousavi, SR Zalavi, NR Farid Hashimoto,s thyroiditis presenting as single hot nodule and hypothyroidism J. Endo Invest. 25:643-645,2002.
  200. Y shi, M Zou, NR Farid The mystery of nm23H1 in thyroid cancer J. Endocrinol.Invest. 25:663-664,2002
  201. V Kaczsur, IA Racz, A Szendroi, M Takacs, NR Farid The cysteine- rich C-flanking region of the thyrotropin receptor has very ancient phylogenetic origins : implications for sequences analysis J.Endocrine Genet. 3:46-54,2002.
  202. V Kaczur, L G Puskas, M Tackacs , IA Racz, A Szendroi, S Toth , S Nagy,C. Szalai, C Balazs ,A Falus ,B Knudsen, NR Farid Evolution of the thyrotropin receptor :A G protein coupled receptor with an intrinsic capacity to dimerize Mol.Genet. Metab.78:2756-290,2003
  203. Y Shi, RS Parhar, M Zou, E Baieti, G Kessie, NR Farid, A.Alzahrani, F. A. Al-Mohanna Gene therapy of anaplastic carcinoma with a single chain interleukin 12 fusion protein Human Gene Therapy 14:1741-1751.
  204. B Knudsen, NR Farid Evolutionary divergence of the thyrotropin receptor function (in press)
  205. Zou M, Famluski KS, Parhar RS, Baiter E, Al-Mohanna FA, Farid NR, Shi Y Microarray analysis of metastatis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis: Identification of S100A4 (Mts1) gene overexpressionas a poor progonostic marker for thyroid carcinoma J. Clin. Endocrino. Metab 89:6146-6154,2004.
  206. Zavaki R, Mousavi Z, Farid NR Thyroglobulin increment after hormone withdrawal is a reliable indicator for the detection of significant remnants or metastases in patients with differentiated thyroid carcinoma Hel. J Nuc. Med 7:199-202,2004
  207. Puskas LG, Juhasz F, Zarva A, Hackler Jr. L, Farid NR The distinction between Graves’ disease and Hashimoto,s thyroiditis by gene profiling J. Endo. Genet 4: 9-22,2005
  208. Puskas LG, Juhasz F, Zarva A, Hackler Jr L , Farid NR Gene profiling idenifies genes specific for well-differentiated epithelial thyroid tumors Mol. Cell. Biol. (in press)
  209. Sheu S-Y, Gorges R, Ensinger C, Ofner D, Farid NR, Stiffert W, Schmid KW Genptypes of yhe GNB3 C825T polymorphism of G protein ßsununit separate adenomas from differentiated thyroid carcinoma of follicular cell origin J. Pathol .(in press)
  210. Zou M, Raid Saleem Al-Baradie RS Farid NR and Shi Y Evaluation of S100A4 (Mts1) gene expression in matched primary and metastatic papillary thyroid carcinomas: overexpression of S100A4 is associated with tumor invasion and metastasis Br. J.Can. ( in press)

Reviews and Editorials

  1. NR Farid and J Anderson. Insulin and sensitivity - a short review and a hypothesis. Sud Med J 10: 236, 1972.
  2. NR Farid and J Anderson. Monograph: The use of micronephelometry in lipoprotein studies. Tamaddoon Printing Press, Khartoum, 1973.
  3. NR Farid. In vitro thyroid function test: a critical review. Newsletter 19: 20, 1977.
  4. NR Farid and JC Bear. The human major histocompatibility complex and endocrine disease. Endocrine Reviews 2: 50, 1981.
  5. NR Farid, R Briones-Urbina, and JC Bear. Graves' disease - the thyroid stimulating antibody and immunological networks. Mol Aspects Med 6: 355, 1983.
  6. NR Farid, R Briones-Urbina, and MN Islam. Anti-idiotypic antibodies as probes for hormone-receptor interaction. Can J Biochem Cell Biol 62: 1255, 1985.
  7. NR Farid and TCY Lo. Anti-idiotypic antibodies as probes for receptor structure and function. Endocrine Reviews 6: 1, 1985.
  8. NR Farid. Anti-hormone anti-idiotypes are probes for receptor structure and function. Immunology Letters 9: 191-199, 1985.
  9. NR Farid, V Stenszky, Cs Balazs and JC Bear. The major histocompatibility complex and thyroid autoimmune disease. Mt. Sinai Medical Journal 53: 6-18, 1986.
  10. NR Farid. Immunologic internal images and hormone receptors. Annales Immunologiae Hungaricae 26: 731-774, 1987.
  11. NR Farid. Are the immune responses to endocrine autoantigens genetically restricted? Autoimmunity 3: 47, 1989.
  12. NR Farid. Screening for congenital hypothyroidism (Editorial). Annals of Saudi Medicine 12: 127-8, 1992.
  13. NR Farid. Understanding the genetics of autoimmune thyroid disease - still an illusive goal. J Clin Endo Met 74: 495A-496A, 1992.
  14. BO Boehm and NR Farid. Molecular aspects of endocrine autoimmunity. Clinical Investigator 71: 79-81, 1993.
  15. NR Farid, YF Shi, and MJ Zou. Molecular basis of thyroid cancer. Endocrine Reviews 15: 202-232, 1994.
  16. NR Farid. Of genes, mice and men... the genetics of common disorders (Editorial). Annals of Saudi Medicine 13: 393-394, 1993.
  17. NR Farid. Thyroid disorders in pregnancy and the postpartum period. Postgraduate Doctor 17: 52-57, 1994.
  18. NR Farid. Multiple endocrine neoplasia type I. Saudi Medical Journal 15: 5-8, 1995.
  19. NR Farid. Towards understanding the molecular basis of thyroid cancer. Annals of Saudi Medicine 15:252-275, 1995.
  20. NR Farid. Genetics of common disorders: recent developments and prospects Postgraduate Doctor19, 100-106, 1996.
  21. NR Farid. Molecular pathogenesis of thyroid cancer: the significance of oncogenes, tumor suppressor genes and genomic instability. Exp. Clin. Endo. & Diabetes 104, 1-12, 1996.
  22. NR Farid, B Brown Graves disease in the new millennium Postgrad. Doctor 12: 65-68, 2000.
  23. NR Farid P53 in thyroid Cancer : tidings from an old foe J.Endo. Invet 24:536-545,2001.
  24. NR Farid, M.Marga The Genetics of Thyroid Associated opthalmopathy: A play in search of characters J.Endocrinol. Invest 26:570-574,2003
  25. H Ayadi, HH Kacem, A Rbai, NR Farid The genetics of autoimmune thyroid disease J.Endocr. Genet ( in press)
  26. NR Farid, MW Zskudlinski Structural and Functional evolution of the thyrotropin receptor Endocrinolgy ( Submitted)
  27. H Ayadi, HH Kacem, A Rebai, NR Farid The genetics of autoimmune thyroid disease Trends Endocr Metab ( in press)
  28. NR Farid & MW Szkudlinski Minireview: Structural and functional evolution the thyrotropin receptor Endocrinology 145:4048-4057, 2004
  29. Hirschowitz E, Farid NR Eating for new metabolic realities- eating low glycemic for life Clev. Clin. Med. J. ( submitted by invitation)

Book Chapters

  1. NR Farid and M Moens. HLA haplotypes in familial Graves' disease. in "Autoimmune Aspects of Endocrine Disorder". A Pinchera, D Doniach, GF Fenzi and L Bashieri (Eds), Academic Press, p. 241, 1980.
  2. NR Farid. Graves' disease. "HLA in Endocrine and Metabolic Diseases" NR Farid (Ed), Academic Press, p. 86, 1981.
  3. NR Farid. Thyroiditis. "HLA in Endocrine and Metabolic Diseases" NR Farid (Ed), Academic Press, p. 146, 1981.
  4. NR Farid, R Briones-Urbina, and MN Islam. Biological activity of anti-thyrotropin anti-idiotypic antibody in "Evolution of Hormone-Receptor Systems". RA Bradshaw and GN Gill (Eds), AR Liss, Inc. p. 55, 1982.
  5. NR Farid and JC Bear in HLA and autoimmune endocrine disorder. "Autoimmune Endocrine Disease". TF Davies (Ed), Wiley and Sons, Inc. p. 59, 1983.
  6. PG Walfish and NR Farid. The immunogenetic basis of autoimmune thyroid disease. in "Autoimmunity and the thyroid". PG Walfish, JR Wall and R Volpe (Eds), Academic Press Inc. Orlando, pp. 9-36, 1985.
  7. NR Farid, GE Fahraeus Van-Ree, and R Briones-Urbina. Structure, Synthesis, Cellular Localization and Immunogenicity of the TSH Receptor in " Autoimmunity and the Thyroid". PG Walfish, JR Wall and R Volpe (Eds), Academic Press Inc. Orlando, pp. 249-271, 1985.
  8. NR Farid. Anti-thyrotropin anti-idotypes as probes for thyrotropin receptor structure and function in "Monoclonal Antibodies and Cancer Therapy". RA Reisfeld and S Sell (Eds), Alan R. Liss, Inc. UCLA Symposia on Molecular and Cellular Biology, New Series, Vol. 27, p 295-316, 1985.
  9. GE Fahraeus Van-Ree and NR Farid. Bovine thyrotropin binding sites in nuclei and nuclear matrix of porcine thyrocytes in G Medeiros-Neto and E Gaitan (edit) "Frontiers in thyroidology", Plenum Medical Book Co. New York, pp. 181-186, 1986.
  10. MN Islam, R Tuppal, BS Hawe, R Briones-Urbina and NR Farid. The microsomal aitp antigen is an epitope of the TSH receptors in G Medeiros-Neto and E Gaitan (ed) "Frontiers in Thyroidology", Plenum Medical Book Co. NY, 1421-24, 1986.
  11. NR Farid. Immunogenetic aspects of endocrine diseases in Cs Csaba, A Leovey and P Szemere (Edit). Proc. XIII Congress Europ. Acad. Alleglory and Clinical Immunology, pp. 275-289, 1986.
  12. NR Farid. Familial goitre in "The thyroid gland: practical clinical treatise", L. Van Middlesworth (Ed) Year Book Medical Publishers, 79-201, 1987.
  13. NR Farid. Immunologic aspects of diabetes mellitus in "Nutrition and Immunology". RK Chandra (Edit), Alan R. Liss Inc. New York, 269-313, 1988.
  14. NR Farid. Anti-idiotype antibodies mimicking active biological substances: in "Elicitation and use of anti-idiotypic antibodies and their biological applications". Constantine A. Bona (Ed), CRC Press Inc. New York, 1988.
  15. NR Farid and GE Fahraeus Van-Ree. Non-isotopic studies of the TSH receptor. in "Immunoassay Technology", S.B. Pal (Ed) 1988, Vol 1, 195-223.
  16. NR Farid and S Linthicum (Eds) Internal image antiidiotypes and receptors in "Anti-idiotype Molecular Mimicry", Springer-Verlag, New York, p. 1-5, 1988.
  17. S Linthicum and NR Farid (Eds). Anti-idiotypic antibodies approach to the study of the TSH receptor in "Anti-idiotype Molecular Mimicry". Springer-Verlag, New York, p. 61-72, 1988.
  18. NR Farid. Immunogenetics of thyroid disorders in Clinics Endocrinol Metabolism N Am, (Guest Ed) JR Wall. W.B. Saunders, Toronto, pp. 229-245, 1988.
  19. NR Farid and V Stenszky. Graves' disease in NR Farid (Ed) Immunogenetics of Endocrine Disorders, Alan R. Liss Inc. New York, pp. 223-266, 1988.
  20. NR Farid and Cs Balazs. Immunogenetics of Thyroiditis and Thyroid carcinoma. in N.R. Farid (Ed) "Immunogenetics of Endocrine Disorders", Alan R. Liss Inc. New York, pp. 267-308, 1988.
  21. NR Farid. Thyroiditis in Conn's Current Therapy, RE Rakel (Ed), W.B. Saunders, Philadelphia, 594-596, 1989.
  22. NR Farid, G Kahaly, and J Beyer. Immunotherapy of Graves' eye disease in GS Eisenbarth (Edit) "Immunotherapy autoimmune diseases", CRC Press Inc. Boca Raton 131-149, 1989.
  23. NR Farid. Principles and methods in the use of anti-idiotypic antibodies as probes of hormone receptor structure and function in John L. Langone (Ed) "Immunology techniques; anti-idiotypic antibodies and molecular mimicry", Methods in Enzymology, Academic Press 178: 191-212, 1990.
  24. Autoimmune thyroid diseases, NR Farid in NR Farid (Ed) "Immunogenetics of Autoimmune Diseases", CRC Press Inc., Boca Raton, FL, Vol 2, 163-177, 1990.
  25. NR Farid. The major histocompatibility complex in endocrine disorders in NR Farid and C Bona (Eds) "Molecular Aspects of Autoimmunity", Academic Press, Orlando, F1. 277-288, 1990.
  26. NR Farid and M Frecker. Immunogenetics of Graves' ophthalmopathy in JR Wall, J. Hawe (Edit) "Graves' Opthalmopathy", Blackwell Publications 47-61, 1990.
  27. NR Farid. Thyroiditis in Conn's Current Therapy, RE Rakel (Ed). W.B. Saunders, Philadelphia, 9, 602-604, 1990.
  28. Y Shi, M Zou, D Berbue, NR Farid Molecular cloning of cDNA fragment for porcine thyrotropin receptor in A Grodon, J Gross ,G Hennemann (Eds ) Progress in Thyroid Research, Proc of 10th International Thyroid Conference pp 99-102 AABelkena,Rotterdam, Brookfoield 1991
  29. NR Farid. Genetic factors in thyroid disease in LE Braverman & RE Utiger (Eds) "Thyroid", J & B Lippincot, Philadelphia pp. 588, 1992.
  30. R Farid, YF Shi, MJ Zou, V Stensky, W Zhonglin, HAF Stephens, GF Bottazo, K Tsuji, M Aizawa, and T Sawazuki (Eds) Hashimoto's thyroiditis is associated with different MHC class II loci. "HLA 1991" Vol I, Oxford University Press pp.759-760, 1992.
  31. NR Farid, YF Shi, MJ Zou, D Robb, K Tsuji, M Aizawa, and T Sasazuki (Eds) Association of Hashimoto's thyroiditis with MHC class II DQ loci. "HLA 1991" Vol II, Oxford University Press pp. 515-519, 1992.
  32. Y Nishimura, E Thorsby, KS Ronningen, NR Farid, et al General organization and overview of the disease component. K Tsuji, M Aizawa, T Sasazuki (Eds) "HLA 1991" Vol I, Oxford University Press pp. 693-700, 1992.
  33. NR Farid, Y Shi, M Zou, V Stenszkey, W Zhonglin, HAF Stephens, and GF Bottatzo. Immunogenetics of Hashimoto's thyroiditis: the 11th Histocomatibility Workshop Experience. S Nagataki, T Mori and K Torizuka(Eds) 80 years of Hashimoto Disease. Elsevier Publishers, Amsterdam, pp. 31-35, 1993.
  34. NR Farid. Thyoiditis in Current Therapy in Endocriology and Metabolism,5th Edition. CW Bardin( Ed), Mosby, St. Louis, pp. 104-107, 1994.
  35. NR Farid, M Zou, and Y Shi. Genetics of Follicular Thyroid Cancer, Endo. and Metab. Clinics N Am K Burman (Guest Ed), 24: 865-885, 1995. WB Saunders Co , Philadelphia PA.
  36. G Semana, NK Mehra, JC Lepetit, J Hors, Z Polymenidis, M Nuwayri Salti, E Quelvennec, BJ Manfras, L Absi, D Maugendre, I Bahon, R Fauchet, M Delamaire, P Vexiau, JP Beressi, U Kanga, DJ Charron, M Benkova, NR Farid, C Loeliger, P Kuehln, H Allannic and BO Boehm. Graves' Disease Study:12th International Histocompatibility Workshop & Conference, 1997. pp404-413.
  37. V Lepage,C Navarette, AArnaiz-Villena, L Contu, NR Farid, S Hashemi,M Kamoun, P Loiseau, E Naumova, L Persoli, JC Poirier, C raffoux, V Schaeffer, C Stavropoulos AHS#12: HLA-DR3(DR17,DR18),DR52 : 12th International Histocompatibility workshop and Conference 1997pp95-99
  38. NR Farid p53 and other cell cycle regulators in Farid (Ed) The Molecular Basis of thyroid cancer Kluwer Academic Publishers, Boston ( in press)
  39. LG Puskas, NR Farid Gene expression in thyroid tumors in NR Farid (Ed) The Molecular Basis of thyroid cancer Kluwer Academic Publishers, Boston ( in press)
  40. Ordonez N, Baloch Z, Matias-Gulu, X, Evans H, Farid NR, Fagin , JA, Kitamura Y, Tallini G, Eng C, Haigh PI, Faquin WC, Sugitani I, Giuffrida D, Boerner S Undifferentiated ( anaplastic) Carcinoma in Chapter 2 Tumors of the Thyroid and Parathyroid in “ Pathology and Genetics: Tumours of Endocrine organs”, World Health Organization Classification of tumours (ed) RA DeLellis, RV. Lloyd, PU Heitz, C Eng IARC Press, Lyon 2004, pp73-76.

Books edited
  1. NR Farid. HLA in Endocrine and Metabolic Disorders. Academic Press, New York, 1981.
  2. NR Farid. Immunogenetic Aspects of Endocrine Disorders. Allan R Liss, New York, 1988.
  3. NR Farid and S Linthicum. Anti-Idiotype Molecular Mimicry. Springer-Verlag, New York, 1988.
  4. NR Farid. Immunogenetics of Autoimmune Disease (TwoVols). CRC Press Inc., Boca Raton, FL, 1990.
  5. NR Farid and CA Bona. Molecular Aspects of Autoimmunity. Academic Press, Orlando, FL, 1990.
  6. NR Farid (Ed) The Molecular Basis of thyroid cancer Kluwer Academic Publishers, Boston ( in press)
  7. J Brand Miller, NR Farid, K Marsh The New Glucose Revolution: managing PCOS Hodder Headline, Australia & Avon, New York ( in press)